What does regulatory affairs earn in DACH pharma 2026?
Regulatory affairs in DACH pays from junior RA specialist (€60,000–75,000) to global head regulatory affairs (€180,000–250,000). Key roles: RA specialist (submissions, labelling), senior RA, RA manager, regional RA lead (DACH/EU), global regulatory lead, head of regulatory affairs. CMC regulatory (module 3), clinical regulatory (module 5), labelling, and EU MDR/IVDR specialist are the best-paid specialisations. Fully remote-capable at CROs (ICON, IQVIA, Parexel); hybrid is the standard at Big Pharma.
What regulatory affairs in pharma actually does
Regulatory affairs (RA) owns all communication and submissions to health authorities — EMA (European Medicines Agency), BfArM (German Federal Institute for Drugs and Medical Devices), Paul Ehrlich Institute, Swissmedic, AGES (Austria) — plus FDA, MHRA, PMDA, and global authorities. Core activities: module 1–5 CTD submissions, marketing authorisation applications (MAA), variations, renewals, pediatric investigation plans, orphan designations, scientific advice meetings, labelling (SmPC, PIL), periodic safety update reports (PSUR), EU MDR and IVDR for medical devices and diagnostics. CMC regulatory (chemistry, manufacturing, controls) and clinical regulatory are separate tracks with their own salary structures.
Who hires regulatory affairs in DACH
Big Pharma sponsor: Bayer, Roche, Novartis, Pfizer Germany, Boehringer Ingelheim, AstraZeneca, GSK, Merck KGaA, Sanofi, Janssen, Lilly, MSD, BMS, AbbVie, Daiichi Sankyo. Specialty biotech: BioNTech, Curevac, Vertex, BioMarin, Alnylam, Moderna, Ipsen, Servier. Generics: Stada, Hexal/Sandoz, Ratiopharm, Mylan/Viatris (higher volume, lower complexity). Medical devices (EU MDR): Siemens Healthineers, Carl Zeiss Meditec, Dräger, B. Braun, Fresenius. CROs as regulatory service: ICON Regulatory, IQVIA Regulatory, Parexel Regulatory Consulting, PPD Regulatory, Voisin Consulting, ProductLife Group. Diagnostics: Roche Diagnostics, Abbott, BD, Bio-Rad. High RA density: Berlin (Bayer, Pfizer), Basel (Roche, Novartis), Ingelheim (BI), Darmstadt (Merck KGaA), Frankfurt (Sanofi).
Salary bands regulatory affairs DACH 2026
Junior RA specialist €60,000–75,000, RA specialist II €75,000–90,000, senior RA €90,000–115,000. Regulatory manager €110,000–135,000, senior RA manager €135,000–160,000. Regional RA lead (DACH/EU) €150,000–185,000. Global regulatory lead (one indication/molecule) €170,000–220,000. Head of regulatory affairs (country/region) €185,000–235,000. Global head regulatory affairs €220,000–300,000+. CMC regulatory pays 5–10% more than clinical regulatory at the same level. EU MDR/IVDR specialists in medical devices command a 10–15% premium. Bonus 15–25% is standard.
The hidden regulatory affairs job market
RA specialist and senior RA are 50–60% visible via LinkedIn, the RAPS job board, and pharma career portals. RA managers and senior managers are 60–70% hidden — specialist headhunters (RAPS recruiters, Real Staffing Regulatory, Hays Life Sciences Regulatory, ProClinical Regulatory). Regional lead and head of regulatory are 80–90% hidden — Egon Zehnder, Heidrick & Struggles, Russell Reynolds for senior executive search. Specialty indications (ATMP, oncology, rare disease, EU MDR) have the highest hidden share because the talent pool is small and regulator expertise is rare.
Regulatory affairs career paths in DACH
Standard path: RA specialist (2–3 years) → senior RA (3–4 years) → RA manager (3–5 years) → regional lead or global lead (5+ years) → head of regulatory affairs. Specialisation in CMC regulatory, clinical regulatory, labelling, EU MDR/IVDR, or specialty indications (ATMP, oncology, rare disease) determines pay and career velocity. CRO → sponsor moves are standard for more depth; sponsor → CRO for breadth. Health-authority experience (BfArM, EMA, PEI) is highly valued — direct moves from authority to industry are common. My Reverse Recruitment helps pick the right specialisation and place candidates precisely.
Frequently asked questions
Which RA specialisation pays best in DACH 2026?
CMC regulatory with ATMP experience (gene, cell therapy) and EU MDR/IVDR specialist in medical devices pay 10–15% above the RA average. Specialty-care regulatory (oncology, rare disease) with 5+ years of experience earn €130,000–180,000. Global regulatory lead in oncology €200,000–250,000.
Is RA in DACH 2026 fully remote-capable?
At CROs (ICON, IQVIA, Parexel, ProductLife) yes — 80%+ of submission roles are fully remote. At Big Pharma sponsor increasingly hybrid (2–3 days office); fully remote contracts have been rare since 2024. In medical devices with EU MDR audit duties, hybrid is the standard because audit presence is required.
How do I move from clinical operations into regulatory affairs?
Moves from clinical operations into clinical regulatory are standard and well achievable — especially with module 5 submissions experience as CRA/CTM. Moves into CMC regulatory are more demanding; without a pharmacy or chemistry background, difficult. Lateral entry from quality assurance into regulatory is common, especially with a GMP background for CMC regulatory.